Cargando…
Antibody responses to BNT162b2 mRNA COVID-19 vaccine in healthcare workers and patients with urological diseases in Japan
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Association of Urology. Published by Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155272/ http://dx.doi.org/10.1016/S0302-2838(22)00120-8 |
| _version_ | 1784718208558694400 |
|---|---|
| author | Hatakeyama, S. Yoneyama, T. Hamaya, T. Togashi, K. Narita, T. Fujita, N. Yamamoto, H. Yoneyama, T. Hashimoto, Y. Ohyama, C. |
| author_facet | Hatakeyama, S. Yoneyama, T. Hamaya, T. Togashi, K. Narita, T. Fujita, N. Yamamoto, H. Yoneyama, T. Hashimoto, Y. Ohyama, C. |
| author_sort | Hatakeyama, S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9155272 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Association of Urology. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91552722022-06-02 Antibody responses to BNT162b2 mRNA COVID-19 vaccine in healthcare workers and patients with urological diseases in Japan Hatakeyama, S. Yoneyama, T. Hamaya, T. Togashi, K. Narita, T. Fujita, N. Yamamoto, H. Yoneyama, T. Hashimoto, Y. Ohyama, C. Eur Urol Article European Association of Urology. Published by Elsevier B.V. 2022-02 2022-06-01 /pmc/articles/PMC9155272/ http://dx.doi.org/10.1016/S0302-2838(22)00120-8 Text en Copyright © 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Hatakeyama, S. Yoneyama, T. Hamaya, T. Togashi, K. Narita, T. Fujita, N. Yamamoto, H. Yoneyama, T. Hashimoto, Y. Ohyama, C. Antibody responses to BNT162b2 mRNA COVID-19 vaccine in healthcare workers and patients with urological diseases in Japan |
| title | Antibody responses to BNT162b2 mRNA COVID-19 vaccine in healthcare workers and patients with urological diseases in Japan |
| title_full | Antibody responses to BNT162b2 mRNA COVID-19 vaccine in healthcare workers and patients with urological diseases in Japan |
| title_fullStr | Antibody responses to BNT162b2 mRNA COVID-19 vaccine in healthcare workers and patients with urological diseases in Japan |
| title_full_unstemmed | Antibody responses to BNT162b2 mRNA COVID-19 vaccine in healthcare workers and patients with urological diseases in Japan |
| title_short | Antibody responses to BNT162b2 mRNA COVID-19 vaccine in healthcare workers and patients with urological diseases in Japan |
| title_sort | antibody responses to bnt162b2 mrna covid-19 vaccine in healthcare workers and patients with urological diseases in japan |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155272/ http://dx.doi.org/10.1016/S0302-2838(22)00120-8 |
| work_keys_str_mv | AT hatakeyamas antibodyresponsestobnt162b2mrnacovid19vaccineinhealthcareworkersandpatientswithurologicaldiseasesinjapan AT yoneyamat antibodyresponsestobnt162b2mrnacovid19vaccineinhealthcareworkersandpatientswithurologicaldiseasesinjapan AT hamayat antibodyresponsestobnt162b2mrnacovid19vaccineinhealthcareworkersandpatientswithurologicaldiseasesinjapan AT togashik antibodyresponsestobnt162b2mrnacovid19vaccineinhealthcareworkersandpatientswithurologicaldiseasesinjapan AT naritat antibodyresponsestobnt162b2mrnacovid19vaccineinhealthcareworkersandpatientswithurologicaldiseasesinjapan AT fujitan antibodyresponsestobnt162b2mrnacovid19vaccineinhealthcareworkersandpatientswithurologicaldiseasesinjapan AT yamamotoh antibodyresponsestobnt162b2mrnacovid19vaccineinhealthcareworkersandpatientswithurologicaldiseasesinjapan AT yoneyamat antibodyresponsestobnt162b2mrnacovid19vaccineinhealthcareworkersandpatientswithurologicaldiseasesinjapan AT hashimotoy antibodyresponsestobnt162b2mrnacovid19vaccineinhealthcareworkersandpatientswithurologicaldiseasesinjapan AT ohyamac antibodyresponsestobnt162b2mrnacovid19vaccineinhealthcareworkersandpatientswithurologicaldiseasesinjapan |